Scott T. Garrett - 07 May 2025 Form 4 Insider Report for HCW Biologics Inc. (HCWB)

Reporting relationship: Director
Issuer ticker: HCWB
Reported as of: 07 May 2025
Net transaction value: +$140,010
SEC form: 4
Accepted by SEC: 09 May 2025, 17:31:26 UTC
Prior SEC filing: 17 Jun 2024
Next SEC filing: 20 May 2025
Source filing: View source filing
Reporting owner signature: /s/ Nicole Valdivieso, as Attorney-in-Fact for Scott T. Garrett

Key filing fact

Scott T. Garrett filed Form 4 for HCW Biologics Inc. (HCWB) on 09 May 2025.

Key facts

This page summarizes Scott T. Garrett's Form 4 filing for HCW Biologics Inc. (HCWB).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 09 May 2025, 17:31.

Change

Previous filing in this sequence was filed on 17 Jun 2024.
Current net transaction value: +$140,010.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001231174 Primary reporting owner

GARRETT SCOTT T

Relationship: Director
Address: C/O HCW BIOLOGICS INC, 2929 N. COMMERCE PARKWAY, MIRAMAR
Signature: /s/ Nicole Valdivieso, as Attorney-in-Fact for Scott T. Garrett
Signature date: 09 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HCWB transaction

Common Stock

Purchase

Transaction value: $140,010
Shares: +5,385
Change %: +80%
Price: $26.00^*
Shares after: 12,082
Date: 08 May 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HCWB transaction Derivative

Common Stock Purchase Warrant

Purchase

Transaction value: $0
Shares: +2,692
Change %
Price: $0.000000
Shares after: 2,692
Date: 07 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,692
Exercise price: $26.00
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These shares are being issued as a portion of and pursuant to the Company entering into a definitive conversion agreement on May 1, 2025, with a conversion date of May 7, 2025, along with 13 other holders of $6.6 million of the outstanding principal of the Secured Notes to convert the Secured Notes for an aggregate of 253,083 shares of the Company's Common Stock at a conversion price of $26.00 per share (on a post-reverse split basis), issuance of an aggregate of 126,540 warrants each exercisable for one share of Common Stock at an exercise price of $26.00 per share (on a post-reverse split basis), and a portion of the 2,174,311 shares of Wugen Inc. common stock held by the Company.